Ventas, Inc. $VTR is Resolution Capital Ltd’s 6th Largest Position

Resolution Capital Ltd lessened its position in Ventas, Inc. (NYSE:VTR) by 19.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,192,008 shares of the real estate investment trust’s stock after selling 1,022,758 shares during the quarter. Ventas accounts for approximately 7.2% of Resolution Capital Ltd’s portfolio, making the stock its 6th largest holding. Resolution Capital Ltd’s holdings in Ventas were worth $342,822,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Dynamic Wealth Strategies LLC bought a new position in shares of Ventas during the 1st quarter valued at about $25,000. Wiser Advisor Group LLC purchased a new position in shares of Ventas during the 3rd quarter valued at about $27,000. IFC & Insurance Marketing Inc. bought a new stake in Ventas in the 4th quarter worth approximately $30,000. Elyxium Wealth LLC bought a new stake in Ventas in the 4th quarter worth approximately $33,000. Finally, Reflection Asset Management purchased a new stake in Ventas in the fourth quarter worth approximately $34,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Price Performance

VTR stock opened at $98.30 on Wednesday. The stock has a market capitalization of $47.79 billion, a price-to-earnings ratio of 178.73, a PEG ratio of 2.15 and a beta of 0.70. The firm’s 50-day moving average price is $88.61 and its two-hundred day moving average price is $85.24. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 12-month low of $65.60 and a 12-month high of $101.60.

Ventas (NYSE:VTR) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.84 earnings per share. As a group, equities analysts predict that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.1%. Ventas’s dividend payout ratio is presently 378.18%.

Insider Activity at Ventas

In other news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.53% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on VTR shares. JPMorgan Chase & Co. increased their price target on shares of Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Monday, May 11th. Jefferies Financial Group boosted their price objective on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Mizuho increased their target price on shares of Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Royal Bank Of Canada increased their target price on shares of Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a report on Monday, May 4th. Finally, Citigroup boosted their price target on shares of Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Fifteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $96.50.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.